Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis

American Journal of Gastroenterology

Volumn 105, Issue 3, 2010, Pages 635-641

  Dhanasekaran, Renumathy ^a   West, Jonathan K ^a   Gonzales, Patrick C ^a   Subramanian, Ram ^a   Parekh, Samir ^a   Spivey, James R ^a   Martin, Louis G ^a   Kim, Hyun S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIURETIC AGENT; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEPATIC HYDROTHORAX; HUMAN; HYDROTHORAX; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SCORING SYSTEM; STENT; SURVIVAL RATE; THORACOCENTESIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYDROTHORAX; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77949274524     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.634     Document Type: Article

References (29)

1. Alberts WM, Salem AJ, Solomon DA, et al. Hepatic hydrothorax. Cause and management. Arch Intern Med 1991;151:2383-2388
2. Islam N, Ali S, Kabir H. Hepatic hydrothorax. Br J Dis Chest 1965;59:222-227
3. Leuallen EC, Carr DT. Pleural effusion;a statistical study of 436 patients. N Engl J Med 1955;252:79-83.
4. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997;17:227-232
5. Alagiakrishnan K, Patel PJ. Left-sided hepatic hydrothorax with ascites. Int J Clin Pract 1999;53:225-226
6. Johnston RF, Loo RV. Hepatic hydrothorax;studies to determine the source of the fluid and report of thirteen cases. Ann Intern Med 1964;61:385-401.
7. Dumont AE, Mulholland JH. Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med 1960;263:471-474
8. Falchuk KR, Jacoby I, Colucci WS, et al. Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis. A new approach to treatment. Gastroenterology 1977;72:319-321
9. Degawa M, Hamasaki K, Yano K, et al. Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt. J Gastroenterol 1999;34:128-131
10. Kidokoro H, Kanazawa H, Nachi T, et al. A case of refractory hepatic hydrothorax successfully treated with transjugular intrahepatic portosystemic shunt]. Nippon Shokakibyo Gakkai Zasshi 2003;100:707-712
11. Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax aft er transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994;106:1293-1295
12. Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997;25:1366-1369
13. Jeffries MA, Kazanjian S, Wilson M, et al. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg 1998;4:416-423
14. Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002;13:385-390
15. Ziv JH, Louis M, John FC, et al. Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol 2003;14:S265-S70.
16. Cardenas A, Kelleher T, Chopra S. Review article:hepatic hydrothorax. Aliment Pharmacol Ther 2004;20:271-279
17. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41:386-400.
18. Strauss RM, Martin LG, Kaufman SL, et al. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994;89:1520-1522
19. D ' Amico G, Morabito A, Pagliaro L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468-475
20. Okazaki I, Maruyama K, Funatsu K, et al. Ten year survival rate of 131 patients with liver cirrhosis excluded the association of liver carcinoma at the establishment of diagnosis. Gastroenterol Jpn 1980;15:350-354
21. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003;52:879-885 (Pubitemid 36613497)
22. Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98:1167-1174
23. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810
24. Deschênes M, Dufresne M, Bui B, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361-1365
25. Madoff DC, Wallace MJ, Ahrar K, et al. TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics 2004;24:21-36;discussion-7.
26. Rossle M, Haag K, Ochs A, et al. The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for variceal bleeding. N Engl J Med 1994;330:165-171
27. Thuluvath P, Bal J, Mitchell S, et al. TIPS for management of refractory ascites:response and survival are both unpredictable. Dig Dis Sci 2003;48:542-550
28. Bureau C, Pagan JCG, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts:long-term results of a randomized multicentre study. Liver Int 2007;27:742-747
29. Siegerstetter V, Deibert P, Ochs A, et al. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt:long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001;13:529-534